Anaprazole Sodium

Products center

Anaprazole Sodium is the first and only proton pump inhibitor with independent intellectual property rights, independently developed by XZenith in China. XZenith owns its global patent rights.

Return

Product features

Domestic new generation of PPI with fully independent intellectual property rights

Indication

Duodenal ulcer
Reflux esophagitis